P057 ADV CLINIC FACIAL ASTRINGENT FOR WOMEN


P057 ADV CLINIC FACIAL ASTRINGENT FOR WOMEN
Posted  February 23, 2021

START DATE03/08/2021
QUALIFICATIONSWomen Ages 18 to 55 with Acne-Prone Skin
TIME REQUIREMENT2 Visits - 20 minutes each
COMPENSATION$35

NOTES:  Study Hours:  8 am until 3 pm (no appointments between 12 & 12:30 p.m.)
* Children, purses or other personal bags are not permitted in the facility at this time.
* You must wear a face mask/covering while in the facility unless asked to remove it.

Visit 1:  Monday, March 8 – 20 minutes
Visit 2; Monday, March 22 – 20 minutes

Inclusion Criteria:

  1. Subject is female and 18-55 years of age.
  2. Subject has self-perceived acne prone skin.
  3. Subject agrees not to introduce any new cosmetic or toiletry products during the study.
  4. Subject is dependable and able to follow directions as outlined in the protocol and anticipates being available for all study visits.
  5. Subject is willing to participate in all study evaluations.
  6. Subject is in generally good health and has a current Panelist Profile Form on file at CRL.
  7. Subject has completed a HIPAA Authorization Form in conformance with 45 CFR Parts 160 and 164.
  8. Subject understands and is willing to sign an Informed Consent Form in conformance with 21 CFR Part 50: “Protection of Human Subjects.”

Exclusion Criteria – A subject is not eligible for study participation if any of the following criteria are met:

  1. Female subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control.
  2. Subject has received treatment with sympathomimetics, antihistamines, vasoconstrictors, non-steroidal anti-inflammatory agents, and/or systemic or topical corticosteroids within one week prior to initiation of the study.
  3. Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would, in the opinion of the Principal Investigator, preclude application of the test material and/or could influence the outcome of the study.
  4. Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study.
  5. Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs.
  6. Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind.
  7. Subject has insulin-dependent diabetes.



Sign up today!